MoreMore

Over the years, we’ve heard many stories from pain warriors who wished their health care providers knew more about chronic pain and ways to manage it. This year, New York lawmakers are taking significant steps to benefit the chronic pain community and better support health care professionals either in training or practicing medicine.

Two bills pain warriors can get excited about

Assembly bill 608 and Assembly bill 9067 (S. 7132) focus on enhancing the state’s current provider education requirements, but in different ways.

Read More

There’s a proposed piece of legislation in Kentucky that would require health plans to cover certain therapies used to treat chronic pain.

As currently written, House Bill 198 would allow pain warriors to have access to receive 20 visits for pain treatments provided by a licensed professional.

Why it matters

Pain care, especially integrative therapy options, are not well-covered by Kentucky health plans, leaving individuals like you with limited options to manage your chronic pain condition.

Read More

U.S. Pain Foundation recently spearheaded a joint letter to the U.S. House Energy and Commerce (E&C) Committee and the E&C Health and Oversight Subcommittees requesting that they convene a hearing about the pain provisions in the SUPPORT for Patients and Communities Act and the recommendations released in May 2019 by the Department of Health and Human Services Pain Management Best Practices Inter-Agency Task Force. The letter was signed by 30 patient and professional groups.

Read More

U.S. Pain Foundation was among several hundred organizations and individuals to weigh in on a recent Food and Drug Administration (FDA) comment period. Specifically, the FDA asked for the public’s views on two main issues:

  1. What criteria the FDA should use to evaluate new opioids to treat pain
  2. What new incentives are needed to better support and encourage the development of new treatments for pain

The comment period came on the heels of a Sept. 17 public hearing at the FDA on these same topics.

U.S. Pain notified its community of the comment period, which ended Nov. 18, via email, social media, and an op-ed by Cindy Steinberg published in National Pain Report.

Read More

We wanted to make you aware of an opportunity to submit public comments to the Food and Drug Administration (FDA). Specifically, the FDA would like the public’s views on two main issues:

  1. What criteria the FDA should use to evaluate new opioids to treat pain
  2. What new incentives are needed to better support and encourage the development of new treatments for pain

On Sept. 17, the FDA held a public hearing called “Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics to Treat Pain and Addiction.” While the public hearing has passed, the FDA is accepting written comments until Nov. 18 at 11:59 pm EST.

Read More

The Centers for Medicare and Medicaid Services (CMS) opened a Request for Information (RFI) to solicit input into the development of an Action Plan on the opioid crisis and the treatment of acute and chronic pain as specified in the SUPPORT Act.

The deadline for comment was Oct. 11.

National Director of Policy and Advocacy Cindy Steinberg submitted on behalf of U.S. Pain Foundation, outlining 10 recommendations for ways CMS could improve pain care.

Read More
Shari Ling, MD, Deputy Chief Medical Officer of CMS, left, with Steinberg

The Center for Medicare and Medicaid Services (CMS) convened a public meeting on Sept. 20 to solicit input into the development of an Action Plan on the opioid crisis and the treatment of acute and chronic pain as specified in the SUPPORT Act. The Action Plan is due to Congress June 1, 2020.

Cindy Steinberg, National Director of Policy and Advocacy, was among the meeting’s speakers as a member of a panel, “Personal Perspectives on Pain and Substance Use Disorders.” To read about her comments on the panel, click here.

Read More

National Director of Policy and Advocacy Cindy Steinberg will speak at a Sept. 20 public meeting at the Centers for Medicare and Medicaid (CMS). At this meeting, CMS is slated to present its Action Plan to address the opioid crisis and pain management, called for in Section 6032 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act passed by Congress in 2018.

Read More

Efforts to disseminate and begin implementing recommendations from the new report from the Pain Management Best Practices Inter-Agency Task Force (PMTF), released in May, are underway.

Most notably, according to a June 3 report from Fox News, Sen. Lamar Alexander—chair of the Senate Health, Education, Labor and Pensions Committee—said that he plans to hold a hearing before the committee that will focus on the task force’s findings. The pain community can take part in an action campaign to encourage a hearing by clicking here.

Read More

The new report on pain management, mandated by Congress and finalized on May 30, is an important milestone for people with pain. The report emphasizes the need for access to affordable, multidisciplinary care, and urges an individualized approach to pain management–instead of broad one-size-fits-all limits and policies.

But how do we move it forward from a piece of paper to actual change?

Read More